Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 8 studies | 28% ± 10% | |
intestine | 6 studies | 30% ± 15% | |
heart | 5 studies | 20% ± 5% | |
brain | 5 studies | 37% ± 10% | |
uterus | 4 studies | 30% ± 13% | |
pancreas | 3 studies | 33% ± 12% | |
placenta | 3 studies | 56% ± 12% | |
eye | 3 studies | 24% ± 7% | |
skin | 3 studies | 24% ± 5% | |
liver | 3 studies | 33% ± 8% | |
adipose | 3 studies | 30% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 7487.46 | 180 / 180 | 100% | 112.91 | 430 / 430 |
breast | 100% | 8422.10 | 459 / 459 | 100% | 162.64 | 1115 / 1118 |
lung | 100% | 11411.23 | 576 / 578 | 100% | 154.75 | 1152 / 1155 |
prostate | 100% | 10261.24 | 244 / 245 | 99% | 118.76 | 499 / 502 |
uterus | 100% | 13399.64 | 170 / 170 | 98% | 113.44 | 452 / 459 |
esophagus | 99% | 10669.26 | 1426 / 1445 | 99% | 96.03 | 181 / 183 |
intestine | 98% | 11581.18 | 950 / 966 | 98% | 101.35 | 518 / 527 |
skin | 97% | 24433.31 | 1757 / 1809 | 99% | 341.15 | 469 / 472 |
stomach | 96% | 7170.89 | 346 / 359 | 99% | 101.55 | 283 / 286 |
bladder | 100% | 13859.67 | 21 / 21 | 95% | 104.91 | 479 / 504 |
thymus | 100% | 8021.91 | 651 / 653 | 94% | 81.47 | 571 / 605 |
pancreas | 93% | 3619.36 | 304 / 328 | 98% | 124.39 | 175 / 178 |
adrenal gland | 99% | 6447.00 | 255 / 258 | 85% | 60.15 | 196 / 230 |
kidney | 85% | 3926.22 | 76 / 89 | 96% | 93.77 | 868 / 901 |
brain | 58% | 1765.04 | 1529 / 2642 | 98% | 95.53 | 691 / 705 |
liver | 71% | 3018.11 | 160 / 226 | 78% | 47.80 | 317 / 406 |
adipose | 100% | 10648.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 20933.20 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.07 | 1 / 1 |
spleen | 98% | 5111.06 | 236 / 241 | 0% | 0 | 0 / 0 |
heart | 98% | 15593.01 | 842 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 81.55 | 44 / 45 |
muscle | 98% | 5273.82 | 784 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 56.69 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 72% | 33.46 | 21 / 29 |
peripheral blood | 21% | 1234.53 | 193 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008150 | Biological process | biological_process |
GO_0042470 | Cellular component | melanosome |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0033018 | Cellular component | sarcoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CALU |
Protein name | Calumenin Calumenin (Crocalbin) (IEF SSP 9302) |
Synonyms | hCG_41656 tcag7.422 |
Description | FUNCTION: Involved in regulation of vitamin K-dependent carboxylation of multiple N-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity (By similarity). . FUNCTION: Involved in regulation of vitamin K-dependent carboxylation of multiple N-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity. . |
Accessions | H0Y875 Q6IAW5 ENST00000249364.9 [O43852-1] ENST00000479257.5 [O43852-3] ENST00000542996.7 [O43852-4] ENST00000535011.6 [O43852-10] ENST00000493278.1 ENST00000449187.7 [O43852-2] O43852 |